Skip to main content
SpringerLink
Log in

Multimodality Management of Localized and Borderline Resectable Pancreatic Adenocarcinoma

  • Chapter
  • First Online:
Book cover Gastrointestinal Oncology

  • 1652 Accesses

Abstract

Adenocarcinoma of the pancreas continues to be a daunting clinical challenge, with approximately 42,000 deaths per year in the United States (Jemal et al. 2009). It is a disease characterized by its late presentation, rapid demise thereafter, and relatively ineffective systemic therapies. Despite this grim prognosis, appreciable progress has been made in the identification of patients with localized disease who may be candidates for potentially curative resections and in the understanding of the technical nuances and efficacy of aggressive surgical procedures. Following initial reports in the 1930s of successful resections for periampullary tumors, the technique known as the Whipple procedure, or pancreaticoduodenectomy, underwent several technical modifications and revisions (Brunschwig 1937; Halsted 1899; Whipple et al. 1935). With time also has come a better understanding of the considerable physiologic impact and sequelae of the procedure and its potential, albeit limited, for cure. The high in-hospital mortality rate during the first several decades after the development of the operation led some to propose that it be abandoned, with risks not sufficiently justified by the low overall survival rates (Crile 1970; Shapiro 1975). By the late 1980s and early 1990s, series from experienced centers indicated that an aggressive surgical approach to periampullary tumors, of which pancreatic cancer is the most common, was justified. Morbidity and mortality rates dramatically improved and median survival rates began to significantly exceed the expected survival times of nonoperative treatment options (Crist et al. 1987; Trede et al. 1990). Today, the overall five-year survival rate is 15–25% for patients who undergo resection, compared with 1–5% for those who do not receive cancer-directed treatment (Bilimoria et al. 2007; Alexakis et al. 2004).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbott DE, Baker MS, Talamonti MS (2010) Neoadjuvant therapy for pancreatic cancer: a current review. J Surg Oncol 101(4):315–320

    Article  CAS  PubMed  Google Scholar 

  • Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91(11):1410–1427

    Article  CAS  PubMed  Google Scholar 

  • Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J et al (2003) Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg 7(6):766–772

    Article  PubMed  Google Scholar 

  • Aristu J, Canon R, Pardo F, Martinez-Monge R, Martin-Algarra S, Manuel Ordonez J et al (2003) Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol 26(1):30–36

    Article  PubMed  Google Scholar 

  • Aston SJ, Longmire WP Jr (1973) Pancreaticoduodenal resection. Twenty years’ experience. Arch Surg 106(6):813–817

    CAS  PubMed  Google Scholar 

  • Bachellier P, Nakano H, Oussoultzoglou PD, Weber JC, Boudjema K, Wolf PD et al (2001) Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 182(2):120–129

    Article  CAS  PubMed  Google Scholar 

  • Backlund DC, Berlin JD, Parikh AA (2010) Update on adjuvant trials for pancreatic cancer. Surg Oncol Clin N Am 19(2):391–409

    Article  PubMed  Google Scholar 

  • Balcom JHT, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C (2001) Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136(4):391–398

    Google Scholar 

  • Barreiro CJ, Lillemoe KD, Koniaris LG, Sohn TA, Yeo CJ, Coleman J et al (2002) Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit? J Gastrointest Surg 6(1):75–81

    Article  PubMed  Google Scholar 

  • Bassi C, Falconi M, Salvia R, Caldiron E, Butturini G, Pederzoli P (2000) Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience. Langenbecks Arch Surg 385(1):10–13

    Article  CAS  PubMed  Google Scholar 

  • Bassi C, Falconi M, Molinari E, Mantovani W, Butturini G, Gumbs AA et al (2003) Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. Surgery 134(5):766–771

    Article  PubMed  Google Scholar 

  • Bilimoria KY, Bentrem DJ, Ko CY, Tomlinson JS, Stewart AK, Winchester DP et al (2007) Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume. Cancer 110(6):1227–1234

    Article  PubMed  Google Scholar 

  • Bilimoria KY, Talamonti MS, Sener SF, Bilimoria MM, Stewart AK, Winchester DP et al (2008) Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg 207(4):510–519

    Article  PubMed  Google Scholar 

  • Bilimoria KY, Bentrem DJ, Lillemoe KD, Talamonti MS, Ko CY (2009) Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst 101(12):848–859

    Article  PubMed  Google Scholar 

  • Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD et al (1999) Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 3(3):233–243

    Article  CAS  PubMed  Google Scholar 

  • Brunschwig A (1937) A one-stage pancreaticoduodenectomy. Surg Gynecol Obstet 65:681–684

    Google Scholar 

  • Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16(7):1727–1733

    Article  PubMed  Google Scholar 

  • Chong M, Freeny PC, Schmiedl UP (1998) Pancreatic arterial anatomy: depiction with dual-phase helical CT. Radiology 208(2):537–542

    CAS  PubMed  Google Scholar 

  • Conlon KC, Dougherty E, Klimstra DS, Coit DG, Turnbull AD, Brennan MF (1996) The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 223(2):134–140

    Article  CAS  PubMed  Google Scholar 

  • Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM et al (2008) Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975–2005). J Clin Oncol 26(21):3511–3516

    Article  PubMed  Google Scholar 

  • Crile G Jr (1970) The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 130(6):1049–1053

    PubMed  Google Scholar 

  • Crist DW, Sitzmann JV, Cameron JL (1987) Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 206(3):358–365

    Article  CAS  PubMed  Google Scholar 

  • Delbeke D, Martin WH (2010) PET and PET/CT for pancreatic malignancies. Surg Oncol Clin N Am 19(2):235–254

    Article  PubMed  Google Scholar 

  • Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN (1998) FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39(6):1030–3

    CAS  PubMed  Google Scholar 

  • Evans DB, Lee JE, Pisters PW (2001) Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Baker RJ, Fischer JE (eds) Mastery of surgery. Lippincott Williams & Wilkins, Philadelphia, pp 1299–1318

    Google Scholar 

  • Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW et al (2008) Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3496–3502

    Article  CAS  PubMed  Google Scholar 

  • Forsmark CE, Lambiase L, Vogel SB (1994) Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA19-9. Pancreas 9(6):731–734

    Article  CAS  PubMed  Google Scholar 

  • Freeny PC, Traverso LW, Ryan JA (1993) Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 165(5):600–606

    Article  CAS  PubMed  Google Scholar 

  • Friess H, Kleeff J, Silva JC, Sadowski C, Baer HU, Buchler MW (1998) The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg 186(6):675–682

    Article  CAS  PubMed  Google Scholar 

  • Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ et al (1994) Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167(1):104–111; discussion 11–13

    Google Scholar 

  • Gulliver DJ, Baker ME, Cheng CA, Meyers WC, Pappas TN (1992) Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability. AJR Am J Roentgenol 159(3):503–507

    CAS  PubMed  Google Scholar 

  • Halsted W (1899) Contributions to the sugery of the bile passages, especially the common bile duct. Boston Med Surg J 141:645–654

    Google Scholar 

  • Harrison LE, Brennan MF (1998) Portal vein resection for pancreatic adenocarcinoma. Surg Oncol Clin N Am 7(1):165–181

    CAS  PubMed  Google Scholar 

  • Heinrich S, Schafer M, Weber A, Hany TF, Bhure U, Pestalozzi BC et al (2008) Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial. Ann Surg 248(6):1014–1022

    Article  PubMed  Google Scholar 

  • Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E et al (2008) Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 26(21):3503–3510

    Article  PubMed  Google Scholar 

  • Herter FP, Cooperman AM, Ahlborn TN, Antinori C (1982) Surgical experience with pancreatic and periampullary cancer. Ann Surg 195(3):274–281

    Article  CAS  PubMed  Google Scholar 

  • Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB III (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 16(1):317–323

    CAS  PubMed  Google Scholar 

  • Ichikawa T, Haradome H, Hachiya J, Nitatori T, Ohtomo K, Kinoshita T et al (1997) Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 202(3):655–662

    CAS  PubMed  Google Scholar 

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249

    Article  PubMed  Google Scholar 

  • Jimenez RE, Warshaw AL, Rattner DW, Willett CG, McGrath D, Fernandez-del Castillo C (2000) Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg 135(4):409–414; discussion 14–15

    Google Scholar 

  • Joensuu TK, Kiviluoto T, Karkkainen P, Vento P, Kivisaari L, Tenhunen M et al (2004) Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 60(2):444–452

    Article  CAS  PubMed  Google Scholar 

  • John TG, Greig JD, Carter DC, Garden OJ (1995) Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg 221(2):156–164

    Article  CAS  PubMed  Google Scholar 

  • Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120(8):899–903

    CAS  Google Scholar 

  • Kamthan AG, Morris JC, Dalton J, Mandeli JP, Chesser MR, Leben D et al (1997) Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 15(8):2920–2927

    CAS  PubMed  Google Scholar 

  • Katz A, Hanlon A, Lanciano R, Hoffman J, Coia L (1998) Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy. Int J Radiat Oncol Biol Phys 41(2):393–396

    Article  CAS  PubMed  Google Scholar 

  • Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5):833–846; discussion 46–48

    Google Scholar 

  • Kim HJ, Czischke K, Brennan MF, Conlon KC (2002) Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 6(5):763–769

    Article  PubMed  Google Scholar 

  • Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230(6):776–782; discussion 82–84

    Google Scholar 

  • Lerut JP, Gianello PR, Otte JB, Kestens PJ (1984) Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients. Ann Surg 199(4):432–437

    Article  CAS  PubMed  Google Scholar 

  • Lin PW, Lin YJ (1999) Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86(5):603–607

    Article  CAS  PubMed  Google Scholar 

  • Lowy AM (2008) Neoadjuvant therapy for pancreatic cancer. J Gastrointest Surg 12(9):1600–1608

    Article  PubMed  Google Scholar 

  • Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P et al (1997) Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226(5):632–641

    Article  CAS  PubMed  Google Scholar 

  • McCarthy MJ, Evans J, Sagar G, Neoptolemos JP (1998) Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 85(3):320–325

    Article  CAS  PubMed  Google Scholar 

  • Megibow AJ, Zhou XH, Rotterdam H, Francis IR, Zerhouni EA, Balfe DM et al (1995) Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability – report of the Radiology Diagnostic Oncology Group. Radiology 195(2):327–332

    CAS  PubMed  Google Scholar 

  • Meszoely IM, Wang H, Hoffman JP (2004) Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986–2003. Surg Oncol Clin N Am 13(4):685–696, x

    Google Scholar 

  • Montgomery RC, Hoffman JP, Riley LB, Rogatko A, Ridge JA, Eisenberg BL (1997) Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 4(7):551–556

    Article  CAS  PubMed  Google Scholar 

  • Mornex F, Girard N, Scoazec JY, Bossard N, Ychou M, Smith D et al (2006) Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: the French SFRO-FFCD 97-04 Phase II trial. Int J Radiat Oncol Biol Phys 65(5):1471–1478

    Article  CAS  PubMed  Google Scholar 

  • Moutardier V, Magnin V, Turrini O, Viret F, Hennekinne-Mucci S, Goncalves A et al (2004) Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 60(2):437–443

    Article  PubMed  Google Scholar 

  • Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S (2003) Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186(2):149–153

    Article  PubMed  Google Scholar 

  • Neoptolemos JP, Kerr DJ, Beger H, Link K, Pederzoli P, Bassi C et al (1997) ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion 58(6):570–577

    Article  CAS  PubMed  Google Scholar 

  • Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H et al (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358(9293):1576–1585

    Article  CAS  PubMed  Google Scholar 

  • Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12):1200–1210

    Article  CAS  PubMed  Google Scholar 

  • Neoptolemos JP, Stocken DD, Tudur Smith C, Bassi C, Ghaneh P, Owen E et al (2009a) Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 100(2):246–250

    Article  CAS  PubMed  Google Scholar 

  • Neoptolemos J, Buchler M, Stocken D et al (2009b) ESPAC-3(v2): a multicenter, international open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. J Clin Oncol 27:18s [suppl; abstr LBA4505]

    Google Scholar 

  • Neuhaus P RH, Post S et al (2008) Deutsche krebsgesellschaft. CONKO-001: final results of the randomized, prospective, multiceneter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). J Clin Oncol 26(Suppl):4504

    Google Scholar 

  • Nieveen van Dijkum EJ, Romijn MG, Terwee CB, de Wit LT, van der Meulen JH, Lameris HS et al (2003) Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 237(1):66–73

    Article  PubMed  Google Scholar 

  • Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297(3):267–277

    Article  CAS  PubMed  Google Scholar 

  • Ohtsuka T, Yamaguchi K, Chijiiwa K, Tanaka M (2001) Postoperative pancreatic exocrine function influences body weight maintenance after pylorus-preserving pancreatoduodenectomy. Am J Surg 182(5):524–529

    Article  CAS  PubMed  Google Scholar 

  • Owens DJ, Savides TJ (2010) Endoscopic ultrasound staging and novel therapeutics for pancreatic cancer. Surg Oncol Clin N Am 19(2):255–266

    Article  PubMed  Google Scholar 

  • Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228(4):508–517

    Article  CAS  PubMed  Google Scholar 

  • Picozzi VJ, Abrams RA, Decker PA, Traverso W et al (2010) Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol [Epub ahead of print]

    Google Scholar 

  • Pipas JM, Barth RJ Jr, Zaki B, Tsapakos MJ, Suriawinata AA, Bettmann MA et al (2005) Docetaxel/gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma. Ann Surg Oncol 12(12):995–1004

    Article  PubMed  Google Scholar 

  • Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S et al (2001a) Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234(1):47–55

    Article  CAS  PubMed  Google Scholar 

  • Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB (2001b) Laparoscopy in the staging of pancreatic cancer. Br J Surg 88(3):325–337

    Article  CAS  PubMed  Google Scholar 

  • Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA et al (2003) Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 7(1):118–126; discussion 27–28

    Google Scholar 

  • Raval MV, Bilimoria KY, Talamonti MS (2010) Quality improvement for pancreatic cancer care: is regionalization a feasible and effective mechanism? Surg Oncol Clin N Am 19(2):371–390

    Article  PubMed  Google Scholar 

  • Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A et al (2008) Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299(9):1019–1026

    Article  CAS  PubMed  Google Scholar 

  • Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J et al (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 9(9):1191–1206

    Article  PubMed  Google Scholar 

  • Ritts RE, Pitt HA (1998) CA 19-9 in pancreatic cancer. Surg Oncol Clin N Am 7(1):93–101

    CAS  PubMed  Google Scholar 

  • Ritts RE Jr, Nagorney DM, Jacobsen DJ, Talbot RW, Zurawski VR Jr (1994) Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease. Pancreas 9(6):707–716

    Article  PubMed  Google Scholar 

  • Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180(2):475–480

    PubMed  Google Scholar 

  • Rosch T (1995) Staging of pancreatic cancer. Analysis of literature results. Gastrointest Endosc Clin N Am 5(4):735–739

    CAS  PubMed  Google Scholar 

  • Rosch T, Dittler HJ, Strobel K, Meining A, Schusdziarra V, Lorenz R et al (2000) Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 52(4):469–477

    Article  CAS  PubMed  Google Scholar 

  • Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL (2002) En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 6(2):147–157; discussion 57–58

    Google Scholar 

  • Satoi S, Yanagimoto H, Toyokawa H, Takahashi K, Matsui Y, Kitade H et al (2009) Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Pancreas 38(3):282–288

    Article  CAS  PubMed  Google Scholar 

  • Schlieman MG, Ho HS, Bold RJ (2003) Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138(9):951–955; discussion 5–6

    Google Scholar 

  • Schlitt HJ, Schmidt U, Simunec D, Jager M, Aselmann H, Neipp M et al (2002) Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg 89(10):1245–1251

    Article  CAS  PubMed  Google Scholar 

  • Sewnath ME, Birjmohun RS, Rauws EA, Huibregtse K, Obertop H, Gouma DJ (2001) The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 192(6):726–734

    Article  CAS  PubMed  Google Scholar 

  • Shapiro TM (1975) Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients. Ann Surg 182(6):715–721

    Article  CAS  PubMed  Google Scholar 

  • Sikora SS, Posner MC (1995) Management of the pancreatic stump following pancreaticoduodenectomy. Br J Surg 82(12):1590–1597

    Article  CAS  PubMed  Google Scholar 

  • Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L (2000) Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 89(2):314–327

    Article  CAS  PubMed  Google Scholar 

  • Sohn TA, Yeo CJ, Cameron JL, Pitt HA, Lillemoe KD (2000) Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg 4(3):258–267; discussion 67–68

    Google Scholar 

  • Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ et al (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15(3):928–937

    CAS  PubMed  Google Scholar 

  • Stewart CJ, Mills PR, Carter R, O’Donohue J, Fullarton G, Imrie CW et al (2001) Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol 54(6):449–455

    Article  CAS  PubMed  Google Scholar 

  • Takai S, Satoi S, Yanagimoto H, Toyokawa H, Takahashi K, Terakawa N et al (2008) Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. Pancreas 36(1):e26–e32

    Article  PubMed  Google Scholar 

  • Talamonti MS, Small W Jr, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM et al (2006) A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 13(2):150–158

    Article  PubMed  Google Scholar 

  • Tanaka M (2004) Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas 28(3):282–288

    Article  PubMed  Google Scholar 

  • Thomas RM, Ahmad SA (2010) Current concepts in the surgical management of pancreatic cancer. Surg Oncol Clin N Am 19(2):335–358

    Article  PubMed  Google Scholar 

  • Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW et al (2004) Pylorus preserving pancreaticoduodenectomy versus standard whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240(5):738–745

    Article  PubMed  Google Scholar 

  • Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211(4):447–458

    Article  CAS  PubMed  Google Scholar 

  • Ujiki MB, Talamonti MS (2005) Surgical management of pancreatic cancer. Semin Radiat Oncol 15(4):218–225

    Article  PubMed  Google Scholar 

  • Ujiki MB, Talamonti MS (2007) Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol 34(4):311–320

    Article  PubMed  Google Scholar 

  • van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ et al (2010) Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362(2):129–137

    Article  PubMed  Google Scholar 

  • van Geenen RC, ten Kate FJ, de Wit LT, van Gulik TM, Obertop H, Gouma DJ (2001) Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 129(2):158–163

    Article  PubMed  Google Scholar 

  • Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13(8):1035–1046

    Article  PubMed  Google Scholar 

  • Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW et al (2008) Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3487–3495

    Article  CAS  PubMed  Google Scholar 

  • Vedantham S, Lu DS, Reber HA, Kadell B (1998) Small peripancreatic veins: improved assessment in pancreatic cancer patients using thin-section pancreatic phase helical CT. AJR Am J Roentgenol 170(2):377–383

    CAS  PubMed  Google Scholar 

  • Warshaw AL, Tepper JE, Shipley WU (1986) Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 151(1):76–80

    Article  CAS  PubMed  Google Scholar 

  • Warshaw AL, Gu ZY, Wittenberg J, Waltman AC (1990) Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 125(2):230–233

    CAS  PubMed  Google Scholar 

  • Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB (2002) Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. Oncologist 7(1):34–45

    Article  PubMed  Google Scholar 

  • Whipple AO, Parsons WB, Mullins CR (1935) Treatment of carcinoma of the ampulla of Vater. Ann Surg 102(4):763–779

    Article  CAS  PubMed  Google Scholar 

  • White RR, Tyler DS (2004) Neoadjuvant therapy for pancreatic cancer: the Duke experience. Surg Oncol Clin N Am 13(4):675–684, ix–x

    Google Scholar 

  • Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA et al (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222(4):580–588; discussion 8–92

    Google Scholar 

  • Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH et al (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225(5):621–633; discussion 33–36

    Google Scholar 

  • Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA et al (2000) Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232(3):419–429

    Article  CAS  PubMed  Google Scholar 

  • Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236(3):355–366; discussion 66–68

    Google Scholar 

  • Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF et al (1993) Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 72(7):2124–2133

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pritzker School of Medicine, University of Chicago, Chicago, IL, USA

    Michael B. Ujiki, Robert Marsh & Mark S. Talamonti

  2. Minimally Invasive Surgery, NorthShore University Health System, Evanston, IL, 60201, USA

    Michael B. Ujiki

  3. Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    William Small

  4. Gastrointestinal Oncology Section, NorthShore University Health System, Evanston, IL, USA

    Robert Marsh

  5. Department of Surgery, NorthShore University Health System, Evanston, IL, USA

    Mark S. Talamonti

Authors
  1. Michael B. Ujiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William Small
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Marsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark S. Talamonti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark S. Talamonti .

Editor information

Editors and Affiliations

  1. Div. Medical Oncology, University of British Columbia, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    Charles D. Blanke

  2. FB 19 Zentrum der Radiologie, Klinik f. Strahlentherapie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, Frankfurt, 60590, Germany

    Claus Rödel

  3. Evanston Northwestern Healthcare, Northwestern University, Ridge Ave. 2650, Evanston, 60201, Illinois, USA

    Mark S. Talamonti

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Ujiki, M.B., Small, W., Marsh, R., Talamonti, M.S. (2011). Multimodality Management of Localized and Borderline Resectable Pancreatic Adenocarcinoma. In: Blanke, C., Rödel, C., Talamonti, M. (eds) Gastrointestinal Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13306-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13306-0_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13305-3

  • Online ISBN: 978-3-642-13306-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation